{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T12:04:05Z","timestamp":1764677045756,"version":"3.46.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["252300420094"],"award-info":[{"award-number":["252300420094"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"DOI":"10.1007\/s13577-025-01326-4","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T12:01:14Z","timestamp":1764676874000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["OTUB2 aggravates pathological cardiac hypertrophy through Rac1 activation"],"prefix":"10.1007","volume":"39","author":[{"given":"Junhui","family":"Xing","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuzhen","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofei","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fen","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hengdao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"issue":"7","key":"1326_CR1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","volume":"15","author":"M Nakamura","year":"2018","unstructured":"Nakamura M, Sadoshima J. Mechanisms of physiological and pathological cardiac hypertrophy. Nat Rev Cardiol. 2018;15(7):387\u2013407. https:\/\/doi.org\/10.1038\/s41569-018-0007-y.","journal-title":"Nat Rev Cardiol"},{"issue":"9","key":"1326_CR2","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1007\/s00204-015-1477-x","volume":"89","author":"YK Tham","year":"2015","unstructured":"Tham YK, Bernardo BC, Ooi JYY, Weeks KL, McMullen JR. Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets. Arch Toxicol. 2015;89(9):1401\u201338. https:\/\/doi.org\/10.1007\/s00204-015-1477-x.","journal-title":"Arch Toxicol"},{"key":"1326_CR3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.yjmcc.2016.06.001","volume":"97","author":"I Shimizu","year":"2016","unstructured":"Shimizu I, Minamino T. Physiological and pathological cardiac hypertrophy. J Mol Cell Cardiol. 2016;97:245\u201362. https:\/\/doi.org\/10.1016\/j.yjmcc.2016.06.001.","journal-title":"J Mol Cell Cardiol"},{"issue":"10","key":"1326_CR4","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1001\/jama.2020.13310","volume":"324","author":"JR Baman","year":"2020","unstructured":"Baman JR, Ahmad FS. Heart failure. JAMA. 2020;324(10):1015. https:\/\/doi.org\/10.1001\/jama.2020.13310.","journal-title":"JAMA"},{"issue":"20","key":"1326_CR5","doi-asserted-by":"publisher","first-page":"6972","DOI":"10.1074\/jbc.RA120.013073","volume":"295","author":"D Sivakumar","year":"2020","unstructured":"Sivakumar D, Kumar V, Naumann M, Stein M. Activation and selectivity of OTUB-1 and OTUB-2 deubiquitinases. J Biol Chem. 2020;295(20):6972\u201382. https:\/\/doi.org\/10.1074\/jbc.RA120.013073.","journal-title":"J Biol Chem"},{"issue":"4","key":"1326_CR6","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s44321-025-00206-6","volume":"17","author":"F Mei","year":"2025","unstructured":"Mei F, Deng D, Cao Z, Lou L, Chen K, Hu M, et al. Deubiquitination of RIPK3 by OTUB2 potentiates neuronal necroptosis after ischemic stroke. EMBO Mol Med. 2025;17(4):679\u201395. https:\/\/doi.org\/10.1038\/s44321-025-00206-6.","journal-title":"EMBO Mol Med"},{"issue":"3","key":"1326_CR7","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.7150\/thno.98660","volume":"15","author":"Y Li","year":"2025","unstructured":"Li Y, Chen X, Xu X, Chen C, Min M, Liang D, et al. OTUB2 contributes to vascular calcification in chronic kidney disease via the YAP-mediated transcription of PFKFB3. Theranostics. 2025;15(3):1185\u2013204. https:\/\/doi.org\/10.7150\/thno.98660.","journal-title":"Theranostics"},{"key":"1326_CR8","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1007\/s00125-013-2889-x","volume":"56","author":"A Beck","year":"2013","unstructured":"Beck A, Vinik Y, Shatz-Azoulay H, Isaac R, Streim S, Jona G, et al. Otubain 2 is a novel promoter of beta cell survival as revealed by siRNA high-throughput screens ofhuman pancreatic islets. Diabetologia. 2013;56:1317\u201326. https:\/\/doi.org\/10.1007\/s00125-013-2889-x.","journal-title":"Diabetologia"},{"issue":"1","key":"1326_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01789-2","volume":"22","author":"W Zhu","year":"2024","unstructured":"Zhu W, Wu C, Liu Z, Zhao S, Huang J. OTU deubiquitinase, ubiquitin aldehyde binding 2 (OTUB2) modulates the stemness feature, chemoresistance, and epithelial-mesenchymal transition of colon cancer via regulating GINS complex subunit 1 (GINS1) expression. Cell Commun Signal. 2024;22(1):420. https:\/\/doi.org\/10.1186\/s12964-024-01789-2.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"1326_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-022-00839-3","volume":"8","author":"S Ouyang","year":"2022","unstructured":"Ouyang S, Zeng Z, Liu Z, Zhang Z, Sun J, Wang X, et al. OTUB2 regulates KRT80 stability via deubiquitination and promotes tumour proliferation in gastric cancer. Cell Death Discov. 2022;8(1):14. https:\/\/doi.org\/10.1038\/s41420-022-00839-3.","journal-title":"Cell Death Discov"},{"issue":"1","key":"1326_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.molcel.2018.10.030","volume":"73","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Du J, Wang S, Shao L, Jin K, Li F, et al. OTUB2 promotes cancer metastasis via Hippo-independent activation of YAP and TAZ. Mol Cell. 2019;73(1):7\u201321. https:\/\/doi.org\/10.1016\/j.molcel.2018.10.030.","journal-title":"Mol Cell"},{"issue":"19","key":"1326_CR12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2315348121","volume":"121","author":"Y Nan","year":"2024","unstructured":"Nan Y, Wu X, Luo Q, Chang W, Zhao P, Zhang L, et al. OTUB2 silencing promotes ovarian cancer via mitochondrial metabolic reprogramming and can be synthetically targeted by CA9 inhibition. Proc Natl Acad Sci USA. 2024;121(19):e2315348121. https:\/\/doi.org\/10.1073\/pnas.2315348121.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"1326_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111561","volume":"41","author":"W Chang","year":"2022","unstructured":"Chang W, Luo Q, Wu X, Nan Y, Zhao P, Zhang L, et al. OTUB2 exerts tumor-suppressive roles via STAT1-mediated CALML3 activation and increased phosphatidylserine synthesis. Cell Rep. 2022;41(4):111561.","journal-title":"Cell Rep"},{"issue":"1","key":"1326_CR14","doi-asserted-by":"publisher","DOI":"10.1080\/080370512024.2387025","volume":"33","author":"X Han","year":"2024","unstructured":"Han X, Xue J, Gao S, Li Y, Duo Y, Gao F. Identification of potential diagnostic biomarkers for hypertension via integrated analysis of gene expression and DNA methylation. Blood Press. 2024;33(1):2387025. https:\/\/doi.org\/10.1080\/080370512024.2387025.","journal-title":"Blood Press"},{"issue":"16","key":"1326_CR15","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1093\/hmg\/ddq232","volume":"19","author":"LC Kudo","year":"2010","unstructured":"Kudo LC, Parfenova L, Vi N, Lau K, Pomakian J, Valdmanis P, et al. Integrative gene\u2013tissue microarray-based approach for identification of human disease biomarkers: application to amyotrophic lateral sclerosis. Hum Mol Genet. 2010;19(16):3233\u201353. https:\/\/doi.org\/10.1093\/hmg\/ddq232.","journal-title":"Hum Mol Genet"},{"key":"1326_CR16","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.yjmcc.2019.01.027","volume":"128","author":"Q-Q Wu","year":"2019","unstructured":"Wu Q-Q, Xiao Y, Liu C, Duan M, Cai Z, Xie S, et al. The protective effect of high mobility group protein HMGA2 in pressure overload-induced cardiac remodeling. J Mol Cell Cardiol. 2019;128:160\u201378. https:\/\/doi.org\/10.1016\/j.yjmcc.2019.01.027.","journal-title":"J Mol Cell Cardiol"},{"issue":"5","key":"1326_CR17","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1182\/blood-2010-05-286831","volume":"117","author":"MV Hoang","year":"2011","unstructured":"Hoang MV, Nagy JA, Senger DR. Active Rac1 improves pathologic VEGF neovessel architecture and reduces vascular leak: mechanistic similarities with angiopoietin-1. Blood. 2011;117(5):1751\u201360. https:\/\/doi.org\/10.1182\/blood-2010-05-286831.","journal-title":"Blood"},{"issue":"5","key":"1326_CR18","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1042\/BST0350996","volume":"35","author":"AP Fields","year":"2007","unstructured":"Fields AP, Frederick LA, Regala RP. Targeting the oncogenic protein kinase C\u03b9 signalling pathway for the treatment of cancer. Biochem Soc Trans. 2007;35(5):996\u20131000. https:\/\/doi.org\/10.1042\/BST0350996.","journal-title":"Biochem Soc Trans"},{"issue":"7","key":"1326_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05948-0","volume":"14","author":"Y Sun","year":"2023","unstructured":"Sun Y, Xu C, Jiang Z, Jiang X. DEF6(differentially exprehomolog) exacerbates pathological cardiac hypertrophy via Rac1. Cell Death Dis. 2023;14(7):483. https:\/\/doi.org\/10.1038\/s41419-023-05948-0.","journal-title":"Cell Death Dis"},{"key":"1326_CR20","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.addr.2020.07.019","volume":"159","author":"J Soppert","year":"2020","unstructured":"Soppert J, Lehrke M, Marx N, Jankowski J, Noels H. Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting. Adv Drug Deliv Rev. 2020;159:4\u201333. https:\/\/doi.org\/10.1016\/j.addr.2020.07.019.","journal-title":"Adv Drug Deliv Rev"},{"issue":"8","key":"1326_CR21","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1161\/cir.0000000000001303","volume":"151","author":"SS Martin","year":"2025","unstructured":"Martin SS, Aday AW, Allen NB, Almarzooq ZI, Anderson CAM, Arora P, et al. 2025 heart disease and stroke statistics: a report of us and global data from the American Heart Association. Circulation. 2025;151(8):e41\u2013660. https:\/\/doi.org\/10.1161\/cir.0000000000001303.","journal-title":"Circulation"},{"issue":"4","key":"1326_CR22","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.jacc.2022.11.023","volume":"81","author":"SJ Greene","year":"2023","unstructured":"Greene SJ, Bauersachs J, Brugts JJ, Ezekowitz JA, Lam CSP, Lund LH, et al. Worsening heart\u00a0failure: nomenclature, epidemiology, and future directions. J Am Coll Cardiol. 2023;81(4):413\u201324. https:\/\/doi.org\/10.1016\/j.jacc.2022.11.023.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1326_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-025-08755-9","volume":"8","author":"Y Wang","year":"2025","unstructured":"Wang Y, Wang Y, Tong F, Gao Q, Li B, Zhao Y. OTUB2\/NR4A1 restrains the development of preeclampsia by suppressing macrophage M1 polarization. Commun Biol. 2025;8(1):1304. https:\/\/doi.org\/10.1038\/s42003-025-08755-9.","journal-title":"Commun Biol"},{"issue":"1","key":"1326_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44466-7","volume":"15","author":"W Ren","year":"2024","unstructured":"Ren W, Xu Z, Chang Y, Ju F, Wu H, Liang Z, et al. Pharmaceutical targeting of OTUB2 sensitizes tumors to cytotoxic T cells via degradation of PD-L1. Nat Commun. 2024;15(1):9. https:\/\/doi.org\/10.1038\/s41467-023-44466-7.","journal-title":"Nat Commun"},{"issue":"4","key":"1326_CR25","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.bbadis.2009.12.009","volume":"1802","author":"EK Kim","year":"2010","unstructured":"Kim EK, Choi E-J. Pathological roles of MAPK signaling pathways in human diseases. Biochim Biophys Acta (BBA)-Mol Basis Dis. 2010;1802(4):396\u2013405. https:\/\/doi.org\/10.1016\/j.bbadis.2009.12.009.","journal-title":"Biochim Biophys Acta (BBA)-Mol Basis Dis"},{"issue":"9","key":"1326_CR26","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1161\/01.res.0000038488.38975.1a","volume":"91","author":"OF Bueno","year":"2002","unstructured":"Bueno OF, Molkentin JD. Involvement of extracellular signal-regulated kinases 1\/2 in cardiac hypertrophy and cell death. Circ Res. 2002;91(9):776\u201381. https:\/\/doi.org\/10.1161\/01.res.0000038488.38975.1a.","journal-title":"Circ Res"},{"issue":"6","key":"1326_CR27","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1006\/jmcc.20001135","volume":"32","author":"T Ueyama","year":"2000","unstructured":"Ueyama T, Kawashima S, Sakoda T, Rikitake Y, Ishida T, Kawai M, et al. Requirement of activation of the extracellular signal-regulated kinase cascade in myocardial cell hypertrophy. J Mol Cell Cardiol. 2000;32(6):947\u201360. https:\/\/doi.org\/10.1006\/jmcc.20001135.","journal-title":"J Mol Cell Cardiol"},{"issue":"4","key":"1326_CR28","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1152\/physrev.00054.2009","volume":"90","author":"BA Rose","year":"2010","unstructured":"Rose BA, Force T, Wang Y. Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. Physiol Rev. 2010;90(4):1507\u201346. https:\/\/doi.org\/10.1152\/physrev.00054.2009.","journal-title":"Physiol Rev"},{"issue":"19","key":"1326_CR29","doi-asserted-by":"publisher","first-page":"7432","DOI":"10.1073\/pnas.0510444103.","volume":"103","author":"M Satoh","year":"2006","unstructured":"Satoh M, Ogita H, Takeshita K, Mukai Y, Kwiatkowski DJ, Liao JK. Requirement of Rac1 in the development of cardiac hypertrophy. Proc Natl Acad Sci USA. 2006;103(19):7432\u20137. https:\/\/doi.org\/10.1073\/pnas.0510444103.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"1326_CR30","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1172\/JCI8497","volume":"105","author":"MA Sussman","year":"2000","unstructured":"Sussman MA, Welch S, Walker A, Klevitsky R, Hewett TE, Price RL, et al. Altered focal adhesion regulation correlates with cardiomyopathy in mice expressing constitutively active rac1. J Clin Investig. 2000;105(7):875. https:\/\/doi.org\/10.1172\/JCI8497.","journal-title":"J Clin Investig"},{"issue":"5","key":"1326_CR31","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1172\/JCI2552","volume":"102","author":"JB Pracyk","year":"1998","unstructured":"Pracyk JB, Tanaka K, Hegland DD, Kim K-S, Sethi R, Rovira II, et al. A requirement for the rac1 GTPase in the signal transduction pathway leading to cardiac myocyte hypertrophy. J Clin Investig. 1998;102(5):929\u201337. https:\/\/doi.org\/10.1172\/JCI2552.","journal-title":"J Clin Investig"},{"issue":"4","key":"1326_CR32","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1128\/mcb.21.4.1173-1184.2001.","volume":"21","author":"A Clerk","year":"2023","unstructured":"Clerk A, Pham FH, Fuller SJ, Sahai E, Aktories K, Marais R, et al. Regulation of mitogen-activated protein kinases in cardiac myocytes through the small G protein Rac1. Mol Cell Biol. 2023;21(4):1173\u201384. https:\/\/doi.org\/10.1128\/mcb.21.4.1173-1184.2001.","journal-title":"Mol Cell Biol"},{"issue":"4","key":"1326_CR33","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1161\/hypertensionaha.120.14752","volume":"76","author":"P-L Li","year":"2020","unstructured":"Li P-L, Liu H, Chen G-P, Li L, Shi H-J, Nie H-Y, et al. STEAP3 (six-transmembrane epithelial antigen of prostate 3) inhibits pathological cardiac hypertrophy. Hypertension. 2020;76(4):1219\u201330. https:\/\/doi.org\/10.1161\/hypertensionaha.120.14752.","journal-title":"Hypertension"},{"issue":"3","key":"1326_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2024.189105","volume":"1879","author":"S Patra","year":"2024","unstructured":"Patra S, Roy PK, Dey A, Mandal M. Impact of HMGB1 on cancer development and therapeutic insights focused on CNS malignancy. Biochim Biophys Acta-Rev Cancer. 2024;1879(3):189105. https:\/\/doi.org\/10.1016\/j.bbcan.2024.189105.","journal-title":"Biochim Biophys Acta-Rev Cancer"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-025-01326-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-025-01326-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-025-01326-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T12:01:16Z","timestamp":1764676876000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-025-01326-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["1326"],"URL":"https:\/\/doi.org\/10.1007\/s13577-025-01326-4","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,2]]},"assertion":[{"value":"13 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"These authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"All animal procedures were approved by the Animal Care and Use Committee of WHUPENN LIFE SCIENCE Co., Ltd (Approval Number: LBSM2025018).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"17"}}